Item 7.01. Regulation FD Disclosure.
On January 13, 2022, Frequency Therapeutics, Inc. (the “Company”) posted an
updated corporate slide presentation in the “Investors & Media” portion of its
website at http://www.frequencytx.com. A copy of the slide presentation is attached as
Exhibit 99.1 to this Current Report on Form 8-K (the “Current Report”).
The information in Item 7.01 of this Current Report, including Exhibit 99.1
attached hereto, is intended to be furnished and shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as
expressly set forth by specific reference in such filing. The Company undertakes
no obligation to update, supplement or amend the materials attached hereto as
Item 9.01. Financial Statements and Exhibits.
The following exhibits relate to Items 7.01, and shall be deemed to be
furnished, and not filed:
Exhibit No. Description 99.1 Frequency Therapeutics, Inc. Corporate Slide Presentation as of January 13, 2022 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source Glimpses